We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Andrx Challenging Shire Patent on Adderall XR
Andrx Challenging Shire Patent on Adderall XR
October 17, 2006
Shire Pharmaceuticals announced Andrx has filed an application to market a generic version of Shire’s attention-deficit/hyperactivity disorder (ADHD) drug Adderall XR.